Stansberry Research

U.S. Midday Stock Moves: MRNA, MAXR, CTAS, FGEN, AOUT

Daniel SmootStansberry NewsWire

Advances:

  • Moderna (MRNA) +7.3%. MRNA will join the S&P 500.
  • Maxar Technologies (MAXR) +5.6%. MAXR shares were initiated as "overweight" at Morgan Stanley.
  • Cintas (CTAS) +2.8%. CTAS shares were upgraded from "neutral" to "outperform" at Baird.

Declines:

  • FibroGen (FGEN) -44%. The U.S. Food and Drug Administration voted against the company's treatment for anemia in chronic kidney disease treatments.
  • American Outdoor Brands (AOUT) -19.9%. AOUT's fourth-quarter revenue disappointed.